##gff-version 3
##sequence-region Q9Y3C5 1 154
Q9Y3C5	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q9Y3C5	UniProtKB	Chain	2	154	.	.	.	ID=PRO_0000056050;Note=RING finger protein 11	
Q9Y3C5	UniProtKB	Zinc finger	99	140	.	.	.	Note=RING-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00175	
Q9Y3C5	UniProtKB	Motif	37	40	.	.	.	Note=PPxY motif	
Q9Y3C5	UniProtKB	Modified residue	14	14	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9Y3C5	UniProtKB	Modified residue	25	25	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9QYK7	
Q9Y3C5	UniProtKB	Modified residue	135	135	.	.	.	Note=Phosphothreonine%3B by PKB/AKT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16123141;Dbxref=PMID:16123141	
Q9Y3C5	UniProtKB	Lipidation	2	2	.	.	.	Note=N-myristoyl glycine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20213681,ECO:0000269|PubMed:20676133;Dbxref=PMID:20213681,PMID:20676133	
Q9Y3C5	UniProtKB	Lipidation	4	4	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20676133;Dbxref=PMID:20676133	
Q9Y3C5	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_058272;Note=D->E;Dbxref=dbSNP:rs12077069	
Q9Y3C5	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Loss of myristoylation. Change in subcellular location: Becomes diffused throughout the cytosol. Strong reduction of ubiquitination. Reduced efficiency of ITCH-binding. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20676133;Dbxref=PMID:20676133	
Q9Y3C5	UniProtKB	Mutagenesis	4	4	.	.	.	Note=Change in subcellular location: Becomes partially cytosolic and retained in association with the Golgi apparatus. Partial reduction of ubiquitination. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20676133;Dbxref=PMID:20676133	
Q9Y3C5	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Loss of GGA1-binding. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20676133;Dbxref=PMID:20676133	
Q9Y3C5	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Loss of GGA1-binding. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20676133;Dbxref=PMID:20676133	
Q9Y3C5	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Loss of GGA1-binding. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20676133;Dbxref=PMID:20676133	
Q9Y3C5	UniProtKB	Mutagenesis	40	40	.	.	.	Note=Loss of ITCH-%2C SMURF2- and WWP1-binding. Partial loss of ubiquitination by ITCH. No effect on STAMBP-binding%3B when associated with S-99 and S-102. Persistent TNF-mediated NFKBIA phosphorylation. Loss of stimulus-dependent complex formation with TAX1BP1%2C TNFAIP3 and RIPK1. Y->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14559117,ECO:0000269|PubMed:14562029,ECO:0000269|PubMed:14755250,ECO:0000269|PubMed:18724389,ECO:0000269|PubMed:19131965;Dbxref=PMID:14559117,PMID:14562029,PMID:14755250,PMID:18724389,PMID:19131965	
Q9Y3C5	UniProtKB	Mutagenesis	99	99	.	.	.	Note=No effect on STAMBP- and SMURF2-binding%3B when associated with S-102. Persistent TNF-mediated NFKBIA phosphorylation. No effect on STAMBP-binding%3B when associated with A-40 and S-102. No effect on ubiquitination by ITCH%3B when associated with S-102. Loss of stimulus-dependent complex formation with TAX1BP1%2C TNFAIP3 and RIPK1. C->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14562029,ECO:0000269|PubMed:14755250,ECO:0000269|PubMed:19131965,ECO:0000269|PubMed:20676133;Dbxref=PMID:14562029,PMID:14755250,PMID:19131965,PMID:20676133	
Q9Y3C5	UniProtKB	Mutagenesis	102	102	.	.	.	Note=No effect on STAMBP- and SMURF2-binding%3B when associated with S-99. No effect on ubiquitination by ITCH%3B when associated with S-102. No effect on STAMBP-binding%3B when associated with A-40 and S-99. C->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14562029,ECO:0000269|PubMed:14755250,ECO:0000269|PubMed:20676133;Dbxref=PMID:14562029,PMID:14755250,PMID:20676133	
Q9Y3C5	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Loss of UBE2N-binding. No gain of UBE2L3-binding. M->A%2CG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18615712;Dbxref=PMID:18615712	
Q9Y3C5	UniProtKB	Mutagenesis	103	103	.	.	.	Note=No effect on UBE2N-binding. No gain of UBE2L3-binding%3B when associated with L-127 and L-128. M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18615712;Dbxref=PMID:18615712	
Q9Y3C5	UniProtKB	Mutagenesis	103	103	.	.	.	Note=No effect on UBE2N-binding. Gain of UBE2L3-binding. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18615712;Dbxref=PMID:18615712	
Q9Y3C5	UniProtKB	Mutagenesis	127	127	.	.	.	Note=No effect on UBE2N-binding. No gain of UBE2L3-binding%3B when associated with L-128. D->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18615712;Dbxref=PMID:18615712	
Q9Y3C5	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No effect on UBE2N-binding. No gain of UBE2L3-binding. D->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18615712;Dbxref=PMID:18615712	
Q9Y3C5	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Loss of phosphorylation and of 14-3-3-binding. T->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16123141;Dbxref=PMID:16123141	
Q9Y3C5	UniProtKB	Sequence conflict	124	124	.	.	.	Note=D->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
